We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current DSKYF market cap is 58.08B. The company's latest EPS is JPY 56.9641 and P/E is 0.53.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 929.72B | 981.79B | 962.52B | 1.04T | 1.28T |
| Operating Income | 83.6B | 139.13B | 63.96B | 73.16B | 107.82B |
| Net Income | 93.42B | 128.97B | 75.83B | 66.97B | 109.19B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 2.09T | 2.11T | 2.09T | 2.22T | 2.51T |
| Total Liabilities | 838.35B | 799.34B | 813.13B | 870.53B | 1.06T |
| Total Equity | 1.25T | 1.31T | 1.27T | 1.35T | 1.45T |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 92.03B | 196.6B | 192.21B | 139.23B | 114.51B |
| Investing | -142.52B | 81.67B | -39.25B | 212.34B | -257.78B |
| Financing | -66.2B | -91.64B | -202.43B | -86.23B | -89.59B |
| Market Cap | 58.08B |
| Price to Earnings Ratio | 0.53 |
| Price to Sales Ratio | 0.05 |
| Price to Cash Ratio | 0.17 |
| Price to Book Ratio | 0.04 |
| Dividend Yield | - |
| Shares Outstanding | 1.92B |
| Average Volume (1 week) | 237k |
| Average Volume (1 Month) | 64.15k |
| 52 Week Change | -14.48% |
| 52 Week High | 37.91 |
| 52 Week Low | 23.45 |
| Spread (Intraday) | 2.05 (6.52%) |
| Company Name | Daiichi Sankyo Co Ltd (PK) |
| Address |
3-5-1 nihonbashi-honcho chuo, tokyo 103-8426 |
| Website | https://www.daiichisankyo.co.jp |
| Industry | pharmaceutical biolog/vaccines (H23) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
